Back to search

Article

Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome

2026-06-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Context</h4> Prader-Willi syndrome is a genetic neurodevelopmental disorder characterized by hyperphagia and early-onset obesity from hypothalamic dysfunction with endocrinopathies and learning disability. Management is challenging with strict control of the food environment needed. While newer glucagon-like peptide-1 receptor agonists, such as semaglutide, have efficacy in non-PWS obesity,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b897080-c980-553e-a63f-22b0a0d4d063
DOI
10.64898/2026.06.11.26354795
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndromeDOI 10.64898/2026.06.11.26354795
Select a neighboring publication to make it the new centre.